Needham analyst Joshua Reilly downgrades Coupa Software (NASDAQ:COUP) from Buy to Hold.
Reported Earlier, Panbela Announces Poster Presentation At Immunology Of Diabetes Society Meeting: Evaluating The Potential Of CPP-1X In Recent Onset Type 1 Diabetes
Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs announces a poster presentation